We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
KBI Biopharma, Inc., a JSR Life Sciences company, established a new commercial manufacturing facility in Research Triangle Park, NC. KBI expects the $150 million, 140,000-sq.-ft. facility to be operational by 1Q22.
JSR Life Sciences, LLC is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA.
KBI Biopharma, a contract development and manufacturing organization (CDMO) and JSR Life Sciences affiliate company, has named Dirk Lange as president and chief executive office.